Marissa Ehringer
Concepts (374)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Nicotinic | 25 | 2025 | 334 | 6.950 |
Why?
| | Polymorphism, Single Nucleotide | 37 | 2025 | 2189 | 4.680 |
Why?
| | Alcohol Drinking | 16 | 2023 | 828 | 2.820 |
Why?
| | Smoking | 23 | 2025 | 1627 | 2.750 |
Why?
| | Tobacco Use Disorder | 12 | 2019 | 251 | 2.370 |
Why?
| | Alcoholism | 14 | 2023 | 807 | 2.320 |
Why?
| | Nerve Tissue Proteins | 11 | 2021 | 596 | 2.050 |
Why?
| | Anxiety | 5 | 2023 | 1035 | 1.820 |
Why?
| | Genetic Predisposition to Disease | 18 | 2025 | 2426 | 1.770 |
Why?
| | Motor Activity | 6 | 2021 | 718 | 1.620 |
Why?
| | Genome-Wide Association Study | 14 | 2024 | 1431 | 1.580 |
Why?
| | Ethanol | 10 | 2017 | 608 | 1.470 |
Why?
| | Nicotine | 6 | 2025 | 334 | 1.170 |
Why?
| | Multigene Family | 4 | 2013 | 198 | 1.110 |
Why?
| | Genotype | 15 | 2020 | 1916 | 1.040 |
Why?
| | Conduct Disorder | 5 | 2014 | 201 | 1.000 |
Why?
| | Behavior, Animal | 5 | 2023 | 501 | 0.990 |
Why?
| | Brain | 7 | 2023 | 2668 | 0.930 |
Why?
| | Phenotype | 18 | 2023 | 3196 | 0.930 |
Why?
| | Mice, Inbred Strains | 5 | 2023 | 409 | 0.920 |
Why?
| | Central Nervous System Depressants | 3 | 2014 | 85 | 0.890 |
Why?
| | Tobacco Products | 3 | 2024 | 138 | 0.880 |
Why?
| | Physical Conditioning, Animal | 2 | 2018 | 257 | 0.850 |
Why?
| | Diazepam | 1 | 2023 | 35 | 0.830 |
Why?
| | Genetic Markers | 3 | 2020 | 344 | 0.830 |
Why?
| | Anti-Anxiety Agents | 1 | 2023 | 46 | 0.820 |
Why?
| | Receptors, GABA-A | 3 | 2016 | 142 | 0.800 |
Why?
| | Cultural Diversity | 1 | 2023 | 77 | 0.790 |
Why?
| | Gene Frequency | 7 | 2016 | 521 | 0.730 |
Why?
| | Genetic Variation | 6 | 2022 | 991 | 0.720 |
Why?
| | Substance-Related Disorders | 9 | 2015 | 1083 | 0.690 |
Why?
| | Choice Behavior | 3 | 2017 | 170 | 0.670 |
Why?
| | Locomotion | 1 | 2021 | 106 | 0.660 |
Why?
| | Marijuana Abuse | 5 | 2012 | 233 | 0.660 |
Why?
| | Haplotypes | 7 | 2015 | 494 | 0.660 |
Why?
| | Genetic Association Studies | 4 | 2016 | 377 | 0.650 |
Why?
| | Nicotinic Agonists | 2 | 2025 | 129 | 0.650 |
Why?
| | Behavior, Addictive | 1 | 2020 | 81 | 0.630 |
Why?
| | Chromosome Mapping | 6 | 2020 | 523 | 0.620 |
Why?
| | Opioid-Related Disorders | 2 | 2024 | 515 | 0.620 |
Why?
| | Transcriptome | 5 | 2023 | 971 | 0.620 |
Why?
| | Parkinson Disease | 1 | 2024 | 493 | 0.570 |
Why?
| | Female | 53 | 2025 | 73304 | 0.560 |
Why?
| | Students | 1 | 2023 | 622 | 0.560 |
Why?
| | Alleles | 5 | 2015 | 891 | 0.550 |
Why?
| | Human Genetics | 1 | 2017 | 3 | 0.550 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2025 | 605 | 0.540 |
Why?
| | Animals | 28 | 2025 | 36940 | 0.540 |
Why?
| | Sex Characteristics | 4 | 2020 | 762 | 0.540 |
Why?
| | Humans | 70 | 2025 | 137585 | 0.540 |
Why?
| | Biomedical Research | 1 | 2023 | 692 | 0.530 |
Why?
| | Male | 54 | 2025 | 67762 | 0.530 |
Why?
| | Siblings | 9 | 2011 | 228 | 0.520 |
Why?
| | Mice | 20 | 2025 | 17787 | 0.520 |
Why?
| | Hippocampus | 3 | 2022 | 895 | 0.510 |
Why?
| | Age of Onset | 7 | 2021 | 518 | 0.510 |
Why?
| | Brain-Derived Neurotrophic Factor | 2 | 2014 | 131 | 0.500 |
Why?
| | Receptors, Metabotropic Glutamate | 1 | 2016 | 40 | 0.500 |
Why?
| | Conscious Sedation | 1 | 2017 | 92 | 0.500 |
Why?
| | Gene Regulatory Networks | 3 | 2023 | 305 | 0.490 |
Why?
| | Gastrointestinal Microbiome | 1 | 2023 | 697 | 0.490 |
Why?
| | Microbiota | 1 | 2023 | 762 | 0.480 |
Why?
| | Gene Expression Regulation | 3 | 2013 | 2607 | 0.480 |
Why?
| | Quantitative Trait Loci | 3 | 2020 | 380 | 0.480 |
Why?
| | Physical Exertion | 1 | 2016 | 215 | 0.460 |
Why?
| | Running | 3 | 2016 | 230 | 0.460 |
Why?
| | Mice, Inbred C57BL | 11 | 2025 | 5757 | 0.450 |
Why?
| | Neurogenesis | 2 | 2015 | 149 | 0.450 |
Why?
| | Anxiety Disorders | 4 | 2023 | 377 | 0.450 |
Why?
| | Corpus Striatum | 1 | 2016 | 167 | 0.450 |
Why?
| | Taste Perception | 1 | 2014 | 31 | 0.440 |
Why?
| | Adolescent | 34 | 2016 | 21513 | 0.440 |
Why?
| | DNA, Intergenic | 1 | 2013 | 26 | 0.410 |
Why?
| | Genetic Testing | 1 | 2016 | 460 | 0.410 |
Why?
| | Receptors, Opioid, mu | 4 | 2019 | 74 | 0.410 |
Why?
| | Longitudinal Studies | 11 | 2019 | 2844 | 0.400 |
Why?
| | Mothers | 1 | 2019 | 754 | 0.400 |
Why?
| | Neurons | 2 | 2020 | 1590 | 0.400 |
Why?
| | Social Environment | 5 | 2007 | 296 | 0.400 |
Why?
| | Up-Regulation | 1 | 2015 | 843 | 0.390 |
Why?
| | Child Behavior Disorders | 2 | 2011 | 144 | 0.390 |
Why?
| | Promoter Regions, Genetic | 3 | 2015 | 1250 | 0.390 |
Why?
| | 3' Untranslated Regions | 1 | 2013 | 145 | 0.390 |
Why?
| | Food Preferences | 1 | 2013 | 119 | 0.390 |
Why?
| | Receptors, Oxytocin | 1 | 2012 | 23 | 0.380 |
Why?
| | Psychology, Adolescent | 2 | 2009 | 66 | 0.370 |
Why?
| | Mental Disorders | 5 | 2020 | 1077 | 0.350 |
Why?
| | Species Specificity | 5 | 2023 | 585 | 0.350 |
Why?
| | Gene Expression | 3 | 2015 | 1502 | 0.350 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2025 | 437 | 0.350 |
Why?
| | Alcohol-Related Disorders | 2 | 2012 | 122 | 0.330 |
Why?
| | Linkage Disequilibrium | 4 | 2013 | 268 | 0.310 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 6 | 2013 | 243 | 0.310 |
Why?
| | Receptor, Cannabinoid, CB1 | 1 | 2009 | 45 | 0.300 |
Why?
| | Genes, Neoplasm | 1 | 2008 | 22 | 0.300 |
Why?
| | Antisocial Personality Disorder | 4 | 2016 | 169 | 0.290 |
Why?
| | Luciferases | 3 | 2013 | 150 | 0.290 |
Why?
| | Internationality | 2 | 2022 | 155 | 0.290 |
Why?
| | Exercise | 1 | 2020 | 2057 | 0.290 |
Why?
| | Mice, Knockout | 6 | 2025 | 3015 | 0.280 |
Why?
| | Case-Control Studies | 9 | 2019 | 3556 | 0.270 |
Why?
| | Mice, 129 Strain | 2 | 2018 | 88 | 0.270 |
Why?
| | Receptors, Cannabinoid | 1 | 2006 | 15 | 0.260 |
Why?
| | Adult | 28 | 2025 | 37929 | 0.260 |
Why?
| | Impulsive Behavior | 2 | 2007 | 150 | 0.260 |
Why?
| | United Kingdom | 2 | 2025 | 318 | 0.260 |
Why?
| | Polymorphism, Genetic | 5 | 2013 | 660 | 0.250 |
Why?
| | Protein Kinase C | 1 | 2007 | 261 | 0.240 |
Why?
| | Exploratory Behavior | 2 | 2021 | 92 | 0.240 |
Why?
| | Analgesics, Opioid | 3 | 2024 | 1000 | 0.240 |
Why?
| | Colorado | 7 | 2020 | 4565 | 0.230 |
Why?
| | Infant, Low Birth Weight | 1 | 2025 | 141 | 0.230 |
Why?
| | Multifactorial Inheritance | 2 | 2023 | 174 | 0.220 |
Why?
| | Chromosomes, Human, Pair 20 | 1 | 2024 | 17 | 0.220 |
Why?
| | Sex Factors | 4 | 2020 | 2071 | 0.210 |
Why?
| | Interdisciplinary Research | 1 | 2023 | 27 | 0.210 |
Why?
| | Disease Models, Animal | 3 | 2023 | 4295 | 0.210 |
Why?
| | Astrocytes | 1 | 2025 | 210 | 0.200 |
Why?
| | Analgesia | 1 | 2024 | 94 | 0.200 |
Why?
| | Epistasis, Genetic | 1 | 2023 | 70 | 0.200 |
Why?
| | Young Adult | 10 | 2016 | 13209 | 0.200 |
Why?
| | Hypnotics and Sedatives | 2 | 2017 | 200 | 0.200 |
Why?
| | Analysis of Variance | 2 | 2017 | 1316 | 0.190 |
Why?
| | Family | 4 | 2011 | 671 | 0.190 |
Why?
| | Tobacco Use | 1 | 2022 | 64 | 0.190 |
Why?
| | Human Genome Project | 1 | 2002 | 15 | 0.190 |
Why?
| | Sequence Analysis, RNA | 2 | 2022 | 452 | 0.180 |
Why?
| | Rats | 3 | 2024 | 5647 | 0.180 |
Why?
| | Maze Learning | 1 | 2021 | 103 | 0.180 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 2 | 2014 | 75 | 0.170 |
Why?
| | Spatial Memory | 1 | 2020 | 26 | 0.170 |
Why?
| | Quantitative Trait, Heritable | 1 | 2001 | 125 | 0.170 |
Why?
| | Dizziness | 2 | 2010 | 82 | 0.160 |
Why?
| | Extinction, Psychological | 1 | 2020 | 86 | 0.160 |
Why?
| | Polymerase Chain Reaction | 2 | 2014 | 1062 | 0.160 |
Why?
| | Transfection | 2 | 2013 | 945 | 0.160 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2010 | 976 | 0.160 |
Why?
| | Computational Biology | 2 | 2020 | 644 | 0.150 |
Why?
| | RNA, Messenger | 3 | 2014 | 2833 | 0.150 |
Why?
| | Repressor Proteins | 1 | 2002 | 427 | 0.150 |
Why?
| | Epigenomics | 1 | 2019 | 115 | 0.150 |
Why?
| | Lung Neoplasms | 2 | 2010 | 2526 | 0.150 |
Why?
| | Mice, Inbred BALB C | 2 | 2020 | 1272 | 0.150 |
Why?
| | Mice, Inbred C3H | 1 | 2018 | 269 | 0.140 |
Why?
| | Smokers | 1 | 2019 | 145 | 0.140 |
Why?
| | Genetic Loci | 2 | 2022 | 288 | 0.140 |
Why?
| | Membrane Proteins | 1 | 2024 | 1164 | 0.140 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2019 | 1040 | 0.140 |
Why?
| | Calmodulin-Binding Proteins | 1 | 2016 | 13 | 0.130 |
Why?
| | GABA Plasma Membrane Transport Proteins | 1 | 2016 | 7 | 0.130 |
Why?
| | Syntaxin 1 | 1 | 2016 | 13 | 0.130 |
Why?
| | Cell Line, Tumor | 2 | 2015 | 3412 | 0.130 |
Why?
| | Proprotein Convertases | 1 | 2016 | 16 | 0.130 |
Why?
| | Receptors, Corticotropin-Releasing Hormone | 1 | 2016 | 29 | 0.130 |
Why?
| | Munc18 Proteins | 1 | 2016 | 24 | 0.130 |
Why?
| | Brain Chemistry | 2 | 2009 | 117 | 0.120 |
Why?
| | Quality Control | 1 | 2016 | 172 | 0.120 |
Why?
| | Sleep | 3 | 2013 | 755 | 0.120 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2016 | 188 | 0.120 |
Why?
| | Potassium Channels | 1 | 2016 | 151 | 0.120 |
Why?
| | Interviews as Topic | 3 | 2007 | 786 | 0.120 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 3 | 2011 | 413 | 0.120 |
Why?
| | Genomics | 1 | 2020 | 795 | 0.120 |
Why?
| | DNA-Binding Proteins | 1 | 2002 | 1502 | 0.120 |
Why?
| | Volition | 1 | 2014 | 34 | 0.110 |
Why?
| | Body Temperature | 1 | 2015 | 222 | 0.110 |
Why?
| | Epigenesis, Genetic | 1 | 2019 | 660 | 0.110 |
Why?
| | Saccharin | 1 | 2013 | 6 | 0.110 |
Why?
| | Vesicular Monoamine Transport Proteins | 1 | 2013 | 7 | 0.110 |
Why?
| | Trans-Activators | 1 | 2016 | 398 | 0.100 |
Why?
| | Europe | 3 | 2022 | 414 | 0.100 |
Why?
| | Cotinine | 1 | 2013 | 77 | 0.100 |
Why?
| | Sweetening Agents | 1 | 2013 | 54 | 0.100 |
Why?
| | Age Factors | 3 | 2017 | 3295 | 0.100 |
Why?
| | Serotonin | 2 | 2008 | 323 | 0.100 |
Why?
| | Base Sequence | 4 | 2013 | 2181 | 0.100 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2016 | 430 | 0.100 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2013 | 86 | 0.100 |
Why?
| | Schizophrenia | 1 | 2017 | 439 | 0.100 |
Why?
| | HEK293 Cells | 1 | 2015 | 730 | 0.100 |
Why?
| | Aging | 2 | 2022 | 1864 | 0.100 |
Why?
| | Adolescent Behavior | 3 | 2014 | 530 | 0.100 |
Why?
| | Reflex, Righting | 1 | 2012 | 15 | 0.100 |
Why?
| | Inhalant Abuse | 1 | 2012 | 3 | 0.100 |
Why?
| | Peer Group | 1 | 2014 | 242 | 0.100 |
Why?
| | Tobacco Smoking | 2 | 2023 | 25 | 0.100 |
Why?
| | Twins | 3 | 2010 | 243 | 0.090 |
Why?
| | Twins, Monozygotic | 3 | 2011 | 203 | 0.090 |
Why?
| | Pedigree | 1 | 2013 | 514 | 0.090 |
Why?
| | Comorbidity | 4 | 2011 | 1622 | 0.090 |
Why?
| | Reward | 1 | 2013 | 244 | 0.090 |
Why?
| | Residence Characteristics | 1 | 2014 | 351 | 0.090 |
Why?
| | Pregnancy | 2 | 2025 | 6763 | 0.090 |
Why?
| | Software | 1 | 2016 | 665 | 0.090 |
Why?
| | Genetic Linkage | 2 | 2008 | 297 | 0.090 |
Why?
| | Research Design | 1 | 2017 | 1139 | 0.080 |
Why?
| | Chromosomes, Human, Pair 15 | 1 | 2010 | 55 | 0.080 |
Why?
| | Middle Aged | 7 | 2022 | 33479 | 0.080 |
Why?
| | Cells, Cultured | 2 | 2025 | 4193 | 0.080 |
Why?
| | Models, Genetic | 2 | 2010 | 600 | 0.080 |
Why?
| | Factor Analysis, Statistical | 2 | 2010 | 283 | 0.080 |
Why?
| | Prevalence | 4 | 2019 | 2734 | 0.080 |
Why?
| | Nuclear Family | 1 | 2009 | 54 | 0.080 |
Why?
| | Darkness | 1 | 2009 | 28 | 0.080 |
Why?
| | Data Interpretation, Statistical | 2 | 2010 | 363 | 0.080 |
Why?
| | Plasmids | 1 | 2010 | 363 | 0.080 |
Why?
| | Alcohol-Induced Disorders, Nervous System | 1 | 2009 | 6 | 0.080 |
Why?
| | Sample Size | 2 | 2022 | 125 | 0.080 |
Why?
| | Socioeconomic Factors | 2 | 2010 | 1289 | 0.080 |
Why?
| | Survival Analysis | 1 | 2012 | 1325 | 0.070 |
Why?
| | Chi-Square Distribution | 1 | 2009 | 530 | 0.070 |
Why?
| | Receptors, Dopamine D2 | 2 | 2006 | 97 | 0.070 |
Why?
| | Disruptive, Impulse Control, and Conduct Disorders | 1 | 2007 | 11 | 0.070 |
Why?
| | United States | 6 | 2019 | 14841 | 0.070 |
Why?
| | Cell Line | 1 | 2013 | 2847 | 0.070 |
Why?
| | Depressive Disorder, Major | 2 | 2011 | 364 | 0.070 |
Why?
| | Risk Factors | 3 | 2025 | 10388 | 0.070 |
Why?
| | Emotions | 1 | 2012 | 548 | 0.060 |
Why?
| | Eating | 1 | 2009 | 380 | 0.060 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2008 | 198 | 0.060 |
Why?
| | MicroRNAs | 1 | 2013 | 692 | 0.060 |
Why?
| | Marijuana Smoking | 1 | 2010 | 252 | 0.060 |
Why?
| | DNA | 2 | 2010 | 1459 | 0.060 |
Why?
| | Glutamic Acid | 1 | 2008 | 246 | 0.060 |
Why?
| | Psychology, Child | 1 | 2006 | 38 | 0.060 |
Why?
| | Self Disclosure | 1 | 2006 | 63 | 0.060 |
Why?
| | Receptors, Dopamine D1 | 1 | 2006 | 34 | 0.060 |
Why?
| | Internal-External Control | 1 | 2006 | 71 | 0.060 |
Why?
| | Biometry | 1 | 2006 | 70 | 0.060 |
Why?
| | Cell Differentiation | 1 | 2013 | 1991 | 0.060 |
Why?
| | Religion | 1 | 2006 | 71 | 0.060 |
Why?
| | Data Collection | 1 | 2008 | 673 | 0.060 |
Why?
| | Monoamine Oxidase | 1 | 2005 | 30 | 0.060 |
Why?
| | Dopamine | 1 | 2008 | 303 | 0.060 |
Why?
| | Linear Models | 1 | 2007 | 849 | 0.060 |
Why?
| | Infant | 1 | 2019 | 9465 | 0.060 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2025 | 100 | 0.060 |
Why?
| | Cannabis | 1 | 2012 | 494 | 0.060 |
Why?
| | Proportional Hazards Models | 1 | 2007 | 1266 | 0.060 |
Why?
| | Smoking Cessation | 1 | 2008 | 442 | 0.050 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2008 | 767 | 0.050 |
Why?
| | Oxycodone | 1 | 2024 | 42 | 0.050 |
Why?
| | Child | 6 | 2015 | 21935 | 0.050 |
Why?
| | Motivation | 1 | 2008 | 570 | 0.050 |
Why?
| | RNA | 1 | 2010 | 921 | 0.050 |
Why?
| | Receptors, Opioid, kappa | 1 | 2003 | 10 | 0.050 |
Why?
| | Cohort Studies | 2 | 2015 | 5742 | 0.050 |
Why?
| | Mice, Congenic | 1 | 2002 | 22 | 0.050 |
Why?
| | Sequence Analysis, Protein | 1 | 2002 | 30 | 0.050 |
Why?
| | Sampling Studies | 1 | 2002 | 99 | 0.050 |
Why?
| | Ataxia | 1 | 2002 | 44 | 0.050 |
Why?
| | Avoidance Learning | 1 | 2003 | 76 | 0.050 |
Why?
| | Birth Weight | 1 | 2025 | 516 | 0.050 |
Why?
| | Open Reading Frames | 1 | 2002 | 123 | 0.050 |
Why?
| | Gene-Environment Interaction | 2 | 2014 | 192 | 0.050 |
Why?
| | Phylogeny | 3 | 2000 | 904 | 0.050 |
Why?
| | Cyclic AMP | 1 | 2002 | 234 | 0.050 |
Why?
| | Gene Silencing | 1 | 2002 | 195 | 0.050 |
Why?
| | Exons | 1 | 2002 | 355 | 0.040 |
Why?
| | Psychopathology | 1 | 2021 | 56 | 0.040 |
Why?
| | Memory, Long-Term | 1 | 2020 | 12 | 0.040 |
Why?
| | Nucleic Acid Hybridization | 1 | 2001 | 190 | 0.040 |
Why?
| | Mice, Mutant Strains | 1 | 2001 | 298 | 0.040 |
Why?
| | Spatial Behavior | 1 | 2020 | 26 | 0.040 |
Why?
| | Ascomycota | 1 | 2000 | 31 | 0.040 |
Why?
| | Eukaryotic Cells | 1 | 2000 | 40 | 0.040 |
Why?
| | Interleukins | 1 | 2022 | 250 | 0.040 |
Why?
| | Fungal Proteins | 1 | 2000 | 123 | 0.040 |
Why?
| | Korarchaeota | 1 | 2000 | 1 | 0.040 |
Why?
| | Endoribonucleases | 1 | 2000 | 81 | 0.040 |
Why?
| | RNA, Catalytic | 1 | 2000 | 187 | 0.040 |
Why?
| | C-Reactive Protein | 1 | 2022 | 410 | 0.040 |
Why?
| | rab4 GTP-Binding Proteins | 1 | 2019 | 9 | 0.040 |
Why?
| | Cytochrome P-450 CYP2B6 | 1 | 2019 | 9 | 0.040 |
Why?
| | Cytochrome P450 Family 2 | 1 | 2019 | 12 | 0.040 |
Why?
| | Child Abuse | 1 | 2005 | 535 | 0.040 |
Why?
| | Protein Isoforms | 1 | 2020 | 404 | 0.040 |
Why?
| | Aryl Hydrocarbon Hydroxylases | 1 | 2019 | 48 | 0.040 |
Why?
| | Archaea | 1 | 2000 | 82 | 0.040 |
Why?
| | Twins, Dizygotic | 2 | 2011 | 175 | 0.040 |
Why?
| | Interleukin-1 | 1 | 2022 | 965 | 0.040 |
Why?
| | Inflammation | 2 | 2022 | 2837 | 0.030 |
Why?
| | Aged | 4 | 2022 | 23961 | 0.030 |
Why?
| | Picrates | 1 | 1996 | 5 | 0.030 |
Why?
| | Psychiatric Status Rating Scales | 2 | 2010 | 547 | 0.030 |
Why?
| | Surveys and Questionnaires | 4 | 2012 | 5778 | 0.030 |
Why?
| | Risk | 1 | 2019 | 912 | 0.030 |
Why?
| | Gram-Positive Bacteria | 1 | 1996 | 48 | 0.030 |
Why?
| | Southeastern United States | 1 | 2014 | 32 | 0.030 |
Why?
| | Transcription, Genetic | 2 | 2013 | 1457 | 0.030 |
Why?
| | Alcoholics | 1 | 2013 | 2 | 0.030 |
Why?
| | Infant, Newborn | 1 | 2025 | 6079 | 0.030 |
Why?
| | Gene Ontology | 1 | 2013 | 53 | 0.030 |
Why?
| | Enkephalins | 1 | 2013 | 20 | 0.030 |
Why?
| | Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2013 | 9 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2019 | 7635 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2002 | 5131 | 0.030 |
Why?
| | Prealbumin | 1 | 2013 | 30 | 0.030 |
Why?
| | Mice, Inbred DBA | 2 | 2003 | 200 | 0.020 |
Why?
| | Myosins | 1 | 2013 | 135 | 0.020 |
Why?
| | Protein Precursors | 1 | 2013 | 134 | 0.020 |
Why?
| | Severity of Illness Index | 2 | 2012 | 2828 | 0.020 |
Why?
| | Exome | 1 | 2013 | 231 | 0.020 |
Why?
| | Adolescent Development | 1 | 2012 | 86 | 0.020 |
Why?
| | DNA, Complementary | 2 | 2002 | 272 | 0.020 |
Why?
| | Molecular Sequence Data | 3 | 2003 | 2900 | 0.020 |
Why?
| | Anxiety, Separation | 1 | 2011 | 16 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2012 | 431 | 0.020 |
Why?
| | Pleasure | 1 | 2010 | 19 | 0.020 |
Why?
| | Tumor Suppressor Proteins | 1 | 2013 | 327 | 0.020 |
Why?
| | Attention Deficit and Disruptive Behavior Disorders | 1 | 2011 | 62 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 4030 | 0.020 |
Why?
| | Sensation | 1 | 2010 | 53 | 0.020 |
Why?
| | Interview, Psychological | 1 | 2010 | 96 | 0.020 |
Why?
| | NF-kappa B | 1 | 2013 | 691 | 0.020 |
Why?
| | Regression Analysis | 1 | 2012 | 1024 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2017 | 3284 | 0.020 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2013 | 539 | 0.020 |
Why?
| | Psychological Tests | 1 | 2010 | 140 | 0.020 |
Why?
| | Models, Psychological | 1 | 2011 | 301 | 0.020 |
Why?
| | Signal Transduction | 1 | 2002 | 5079 | 0.020 |
Why?
| | Mouth Mucosa | 1 | 2007 | 92 | 0.020 |
Why?
| | Juvenile Delinquency | 1 | 2007 | 108 | 0.020 |
Why?
| | Cheek | 1 | 2006 | 17 | 0.020 |
Why?
| | Hypoxia | 1 | 2013 | 1112 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2013 | 1774 | 0.020 |
Why?
| | Genome, Human | 1 | 2008 | 425 | 0.010 |
Why?
| | Environment | 1 | 2007 | 358 | 0.010 |
Why?
| | Confidence Intervals | 1 | 2006 | 329 | 0.010 |
Why?
| | Taq Polymerase | 1 | 2004 | 10 | 0.010 |
Why?
| | Logistic Models | 1 | 2010 | 2074 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2010 | 2031 | 0.010 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2003 | 155 | 0.010 |
Why?
| | Child Behavior | 1 | 2005 | 248 | 0.010 |
Why?
| | Colforsin | 1 | 2002 | 53 | 0.010 |
Why?
| | Isoproterenol | 1 | 2002 | 113 | 0.010 |
Why?
| | Drug Tolerance | 1 | 2002 | 105 | 0.010 |
Why?
| | Adrenergic beta-Agonists | 1 | 2002 | 134 | 0.010 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2002 | 145 | 0.010 |
Why?
| | Retrospective Studies | 2 | 2010 | 15657 | 0.010 |
Why?
| | Genes, Tumor Suppressor | 1 | 2001 | 86 | 0.010 |
Why?
| | Ribonuclease P | 1 | 2000 | 22 | 0.010 |
Why?
| | Antigens, Surface | 1 | 2001 | 154 | 0.010 |
Why?
| | Consensus Sequence | 1 | 2000 | 73 | 0.010 |
Why?
| | Genes, Fungal | 1 | 2000 | 52 | 0.010 |
Why?
| | Enzymes | 1 | 2001 | 67 | 0.010 |
Why?
| | Ion Channels | 1 | 2001 | 133 | 0.010 |
Why?
| | Oncogenes | 1 | 2001 | 116 | 0.010 |
Why?
| | DNA, Fungal | 1 | 2000 | 80 | 0.010 |
Why?
| | Wyoming | 1 | 2000 | 36 | 0.010 |
Why?
| | Sequence Alignment | 1 | 2000 | 343 | 0.010 |
Why?
| | DNA, Archaeal | 1 | 2000 | 17 | 0.010 |
Why?
| | Catalytic Domain | 1 | 2000 | 207 | 0.010 |
Why?
| | Blotting, Western | 1 | 2002 | 1226 | 0.010 |
Why?
| | Postural Balance | 1 | 2002 | 215 | 0.010 |
Why?
| | Structure-Activity Relationship | 1 | 2000 | 570 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 2000 | 316 | 0.010 |
Why?
| | Alternative Splicing | 1 | 2001 | 229 | 0.010 |
Why?
| | DNA, Bacterial | 1 | 2000 | 337 | 0.010 |
Why?
| | Microscopy, Fluorescence | 1 | 2000 | 402 | 0.010 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2000 | 549 | 0.010 |
Why?
| | Nucleic Acid Conformation | 1 | 2000 | 728 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2002 | 2167 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 2000 | 812 | 0.010 |
Why?
| | Temperature | 1 | 2000 | 679 | 0.010 |
Why?
| | Evolution, Molecular | 1 | 2000 | 493 | 0.010 |
Why?
| | Industrial Waste | 1 | 1996 | 6 | 0.010 |
Why?
| | Zebrafish | 1 | 2000 | 499 | 0.010 |
Why?
| | Biodegradation, Environmental | 1 | 1996 | 84 | 0.010 |
Why?
| | Biological Evolution | 1 | 2000 | 474 | 0.010 |
Why?
| | Fatty Acids | 1 | 1996 | 443 | 0.010 |
Why?
| | Transcription Factors | 1 | 2001 | 1719 | 0.010 |
Why?
| | Time Factors | 1 | 2001 | 6828 | 0.010 |
Why?
| | Mutation | 1 | 2000 | 3958 | 0.000 |
Why?
|
|
Ehringer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|